Syngenta Biotechnology, a division of the Swiss giant agribusiness company Syngenta, has begun construction of an R&D center in Beijing. When the company announced its intention to build the center, it committed $100 million to developing the project over the next five years. The China facility will concentrate on evaluating genetic modifications for key crops such as corn and soybeans, with the goal of improving yields, drought resistance, disease control and biomass conversion for biofuels. More details...

Stock Symbol: (NYSE: SYT)